Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis

被引:37
|
作者
Sharief, MK [1 ]
Semra, YK [1 ]
机构
[1] Guys Hosp, Dept Neuroimmunol, Guys Kings & St Thomas Sch Med, London SE1 9RT, England
关键词
multiple sclerosis; cerebrospinal fluid; intrathecal; apoptosis; survivin;
D O I
10.1016/S0165-5728(01)00389-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The perpetuation of the inflammatory process in multiple sclerosis (MS) may arise from the failure to eliminate potentially pathogenic autoreactive lymphocytes by programmed cell death (apoptosis). Such impairment may be caused by multiple abnormalities of apoptosis regulatory proteins. In this study, we investigated the expression of survivin, a recently described cell cycle-regulated antiapoptosis protein, in lymphocytes from patients with active relapsing-remitting MS and appropriate controls. Survivin reactivity was detected in intrathecal lymphocytes from some MS patients, but not in resting peripheral lymphocytes. However, mitogen stimulation of resting lymphocytes induced survivin expression, which was significantly higher in stimulated intrathecal and peripheral T lymphocytes from MS patients when compared to controls. In contrast, cellular expression of the antiapoptosis protein Bcl-2 was relatively similar between MS patients and the control groups. Moreover, heightened survivin expression in MS patients correlated with T lymphocyte resistance to apoptosis, and was independent of cellular expression of the death receptor Fas. These findings suggest that upregulation of the antiapoptotic protein survivin in mitogen-stimulated T lymphocytes is a feature of multiple sclerosis. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:358 / 364
页数:7
相关论文
共 50 条
  • [31] Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis
    Sharief, MK
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 109 (02) : 236 - 243
  • [32] Altered microRNA expression in lymphocytes of relapsing-remitting multiple sclerosis patients
    Lindberg, Raija L.
    Hoffmann, Francine
    Kuhle, Jens
    Mehling, Matthias
    Kappos, Ludwig
    MULTIPLE SCLEROSIS, 2008, 14 : S15 - S16
  • [33] Expression of Semaphorin CD100 on Peripheral Blood Lymphocytes from Patients with Remitting Multiple Sclerosis
    Trushnikova T.N.
    Baidina T.V.
    Danchenko I.Y.
    Kuklina E.M.
    Nekrasova I.V.
    Neuroscience and Behavioral Physiology, 2015, 45 (3) : 338 - 341
  • [34] INTERFERON-PRODUCTION BY LYMPHOCYTES FROM MULTIPLE-SCLEROSIS AND NON-MULTIPLE-SCLEROSIS PATIENTS
    TOVEL, DR
    MCROBBIE, IA
    WARREN, KG
    TYRRELL, DLJ
    NEUROLOGY, 1983, 33 (05) : 640 - 643
  • [35] T-LYMPHOCYTES AND B-LYMPHOCYTES IN MULTIPLE-SCLEROSIS
    LISAK, RP
    LEVINSON, AI
    ZWEIMAN, B
    ABDOU, NI
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1975, 22 (01): : 30 - 34
  • [36] OLIGODENDROGLIAL TOXICITY BY SERUM AND LYMPHOCYTES FROM PATIENTS WITH MULTIPLE-SCLEROSIS
    FEWSTER, ME
    ELLISON, GW
    MYERS, LW
    KURASHIGE, EY
    NEUROLOGY, 1975, 25 (08) : 735 - 739
  • [37] Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients
    Rajda, C
    Bencsik, K
    Vécsei, L
    Bergquist, J
    JOURNAL OF NEUROIMMUNOLOGY, 2002, 124 (1-2) : 93 - 100
  • [38] The Role of γδT-Lymphocytes in Multiple Sclerosis Immunopathogenesis
    Nizheharodava, Darya
    Bagatka, Svetlana
    Lisovskaya, Nadya
    Kolobova, Marija
    Motuzova, Jana
    Zafranskaya, Marina
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 71 (06) : 489 - 489
  • [39] Mechanisms of statins in multiple sclerosis - Preferential inhibition of activated T lymphocytes by an at least triple mode of action
    Neuhaus, O
    Manda, VS
    Stuve, O
    Archelos, JJ
    Hartung, H
    NEUROLOGY, 2006, 66 (05) : A176 - A176
  • [40] T-SUPPRESSOR LYMPHOCYTES IN MULTIPLE-SCLEROSIS
    HUDDLESTONE, JR
    OLDSTONE, MBA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1980, 39 (03): : 362 - 362